- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05254587
Accuracy of IOLMASTER 700 Total Keratometry (TK)
Accuracy of IOLMASTER 700 Total Keratometry (TK) in Patients Undergoing Post-Laser Vision Correction Cataract Surgery
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Orly Shiler
- Phone Number: 310-229-1220
- Email: orlyjr@inorbit.com
Study Locations
-
-
California
-
Bakersfield, California, United States, 93309
- Recruiting
- Empire Eye & Laser Center
-
Principal Investigator:
- Daniel Chang, M.D.
-
Contact:
- Jacque Whinery
- Phone Number: 661-325-3937
- Email: jwhinery@empireeyeandlaser.com
-
Los Angeles, California, United States, 90067
- Recruiting
- Advanced Vision Care
-
Principal Investigator:
- Nicole Fram, MD
-
Contact:
- Orly Shiler
- Phone Number: 310-229-1220
- Email: orlyjr@inorbit.com
-
Torrance, California, United States, 90505
- Recruiting
- Wolstan & Goldberg Eye Associates
-
Contact:
- Cynthia Hernandez Montes
- Phone Number: 310-602-5640
- Email: cynthia@wgeye.com
-
Principal Investigator:
- Damien Goldberg, MD
-
-
Maryland
-
Bowie, Maryland, United States, 20716
- Completed
- Solomon Eye Physicians and Surgeons
-
-
Pennsylvania
-
Bala-Cynwyd, Pennsylvania, United States, 19004
- Recruiting
- Ophthalmic Partners PC
-
Contact:
- Gwen Toti
- Phone Number: 484-434-2706
- Email: gtoti@oppdoctors.com
-
Principal Investigator:
- Brandon Ayres, MD
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Not yet recruiting
- MUSC Storm Eye Institute29425
-
Contact:
- Nikki Weas
- Phone Number: 843-792-2338
- Email: weasn@musc.edu
-
Principal Investigator:
- Karolinne Rocha, MD, PhD
-
-
Virginia
-
Norfolk, Virginia, United States, 23502
- Recruiting
- Virginia eye consultant
-
Principal Investigator:
- Elizabeth Yeu, M.D.
-
Contact:
- Joshua Hammond
- Phone Number: 757-622-2200
- Email: joshuahammond@eyecare-partners.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults, 18 years of age or older at the time of cataract surgery.
Patient has had LVC and IOL cataract surgery within 3 years or is scheduled to undergo IOL cataract surgery performed for the treatment of visually significant cataracts.
Note: The only IOLs permitted for use in this study are Monofocal (ZCBOO, LI61AO, SN60WF, SA60WF, MX60E) and Toric Lenses (Tecnis 2 ZCU, ZCT, SN6ATx, SA6ATx, MX60ET).
- Best corrected distance visual acuity (BCDVA) potential of 20/30 or better (as measured by Retinal Acuity Meter (RAM) or Potential Acuity Meter (PAM).
- Patients who have a manifest refraction that is myopic or hyperopic after previous LVC.
- Patients that have biometric measurements (including Axial Length) for the IOL cataract surgery that were performed preoperatively with the IOLMaster700, including Barrett True K /TK.
- Signed and received a copy of the signed written informed consent (pertain to the prospective subjects only).
- For prospective patients, willingness and ability to comply with schedule for follow-up visits and postoperative evaluations.
Exclusion Criteria:
Patients with a history of any of the following:
- Corneal pathology - Epithelial Basement Membrane Dystrophy (EMBD), Irregular Astigmatism, Decentered LASIK/PRK, Radial Keratotomy (RK), Fuchs Dystrophy
- Retinal pathology - Visually significant Epiretinal Membrane (ERM) with loss of foveal contour, Large/ Medium Drusen, Cystoid Macular Edema (CME), History of Retinal Detachment
- Optic neuropathy
- Advanced glaucoma
- Amblyopia
- Strabismus
- Relative Afferent Pupillary Defect (RAPD) indicating an optic neuropathy.
- Patients with a previous history of small incision lenticule extraction (SMILE) surgery and/or glaucoma filtering procedure (defined as tubes or trabeculectomy) other than photorefractive keratectomy (PRK) or LASIK.
- Patient who had to undergo A-scan measurement to retrieve Axial Length (AL) values.
- Patient has had LVC and IOL cataract surgery within 3 years or is scheduled to undergo IOL cataract surgery performed for the treatment of visually significant cataracts with the presence or intention of implanting a multifocal, extended depth of focus, accommodating and light adjustable lens (such as, but not limited to, TFAT / TFNT; DAT / DFT; ICB00/DIB/DIU/DAT; ZXT; DFW; SN6AD1; AT-50; RxSIGHT).
- Patients in whom the study eye experiences any intraoperative surgical complications or complex cataract surgeries (vitrectomy, corneal suturing).
- Patients with previous LVC where one eye was treated for myopia and the other eye was treated for hyperopia.
- Patient is participating in another study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Retrospective
|
4 different intraocular lens (IOL) calculation methods (Haigis TK, ASCRS calculator, Barrett True K Classic K, Barrett True K TK) will be performed using the preoperative biometry and post operative refraction data.
|
Prospective
|
4 different intraocular lens (IOL) calculation methods (Haigis TK, ASCRS calculator, Barrett True K Classic K, Barrett True K TK) will be performed using the preoperative biometry and post operative refraction data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Keratometry Accuracy Assessment
Time Frame: 4 Weeks
|
Subjects utilizing Total Keratometry within (+/- 0.50 D, +/- 0.75 D, +/- 1.00 D) compared to the proportion of subjects utilizing traditional keratometry readings.
|
4 Weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nicole Fram, MD, Advanced Vision Care
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AVC-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on IOLMASTER 700 TK
-
OFTALVIST (Oftalmología Vistahermosa S.L)Completed
-
Multack Eye CareCompleted
-
Prim. Prof. Dr. Oliver Findl, MBACompleted
-
Peking University Third HospitalNot yet recruiting
-
Walailak UniversityRecruiting
-
Democritus University of ThraceCompleted
-
Mahidol UniversityCompleted
-
Ziemer Ophthalmic Systems AGCompleted
-
Teikoku Seiyaku Co., Ltd.ClinSearch; CRM Biometrics GmbH; SocraTec R&D GmbH; SocraMetrics GmbH; Clinigen Clinical...Completed
-
AGC Biologics S.p.A.CompletedHematological MalignanciesItaly, Israel, United Kingdom, Germany, Greece